Photos: 

Some evaluation reports are public and can be downloaded from this website, while others are restricted to MSF users and can only be accessed via Tukul. This limitation is mainly due to the sensitive nature of the operational contexts and the resulting content. However, there are internal discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

Country/Region

The objective of this lessons learnt exercise was to assess the advantages and disadvantages of the UNITAID grant governance and management model for project achievements in terms of medical (and related) outcomes, strategic decisions, the potential for collaboration between multiple MSF entities and to leverage the learnings for replication in future projects. The exercise showed that the project directly delivered a new, more effective, simpler and much cheaper treatment to patients across seven countries.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Hugues Juillerat, Sharon McClenaghan and Glenn O’Neil of TRAASS International.
15/01/2019

This document describes the project Lessons identified at the end of the market entry planning phase for MSF in Finland. It summarises the successes and challenges encountered during the project, lists the learning themes arising from these successes and challenges, and includes a set of lessons derived from an analysis of these learning points. The Annex contains a proposed (brief) framework with criteria and pre-requisites for a successful Market Entry Plan in MSF based on this experience. NOTE: This is not an evaluation and therefore there is no ambition for independent judgement.

This Retrospect was facilitated by the Stockholm Evaluation Unit on behalf of the Project Team. The report has been prepared by Timothy McCann.
30/10/2017

SSP was formed in the aftermath of a high profile depot crisis in South Africa in 2012/3, with six organisations, already dealing with drug stock outs joining forces to tackle the issue. The different organisations brought different skills to the table. Largely focused on anti-retrovirals (ARVs) and TB medication, from the beginning the SSP has tasked itself to hold government accountable, to perform a watchdog role and to present the patient view on stock outs.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Andrew McKenzie and Timothy McCann.
11/01/2017

Given that community HIV testing is often more expensive than HF-based testing, this evaluation aims to fully understand the relative advantages of community testing modalities. MSF has been providing 3 modalities of community HIV testing in KZN since late 2012, to complement the standard, health facility (HF)-based testing provided by the Department of Health. Fixed sites (FS), Mobile 1-Stop Shops (M1SS) and Door-to-Door Community Health Agents (CHAPs) provide testing throughout the project area of Eshowe, Mbongolowane and the adjacent rural areas.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Richard Bedell.
21/04/2016

This report describes the OCB Khayelitsha Project, initiated in 2000, as one of the first MSF projects in Africa to introduce antiretroviral treatment (ART) into the public sector. Currently implementing HIV and tuberculosis (TB) programs, it has produced dozens of very well-received publications in peer-reviewed scientific journals, in large part because of its innovative strategies, major investment in a locally driven monitoring and evaluation system, and a long-standing collaboration with the University of Cape Town (UCT), civil society and local health authorities.

Stockholm Evaluation Unit
10/04/2014

This report describes the OCB Khayelitsha Project, initiated in 2000, as one of the first MSF projects in Africa to introduce antiretroviral treatment (ART) into the public sector. Currently implementing HIV and tuberculosis (TB) programs, it has produced dozens of very well-received publications in peer-reviewed scientific journals, in large part because of its innovative strategies, major investment in a locally driven monitoring and evaluation system, and a long-standing collaboration with the University of Cape Town (UCT), civil society and local health authorities.

Stockholm Evaluation Unit
10/04/2014

This evaluation aimed at gaining perspective on and learning from current partnership practices, informing the debate on MSF’s policy on partnerships and providing guidance for future engagement. Four separate field evaluations in DRC, Kenya, Niger and North Korea as well as a desk review of seven additional partnerships have been conducted. The report provides good practice examples and practical recommendations.

Karima Hammadi and Annie Désilets
01/02/2012

Through an analysis of the events that have marked MSF’s history since 2003, this series of case studies and historical accounts describes the evolution of MSF's humanitarian ambitions, the resistance to these ambitions and the political arrangements that overcame this resistance (or that failed to do so).

edited by Claire Magone, Michaël Neuman, Fabrice Weissman
22/11/2011

Since civil unrest and violence erupted in countries across Northern Africa and the Middle East (referred as NAME in the document) teams from the five MSF OCs (Operational Centres) have been assisting the populations. OCB has mainly been active in Egypt, Bahrain, Libya and Italy (Lampedusa with the influx of migrants from the Northern African regions). Activities and challenges have varied from one context to another. The overall aim of the mapping/compilation is to describe all of OCB’s activities from January to August 2011, in relation to the unrests.

David Crémoux
01/09/2011

The review analyses the timeliness and relevance of MSF emergency response, taking into account local actors and environment in Japan. Despite a good reactivity and explorations in remote areas affected (relevant), MSF actions can gain in efficiency (E-Prep, list of contacts, better knowledge of national strategies, etc). Capitalisation on Nuclear risks remains an issue to consider seriously.

FPENFEUNTEUN
01/07/2011

Pages